Total Payments
$15,113
2024 Payments
$3,712
Companies
56
Transactions
616
Medicare Patients
399
Medicare Billing
$7,022
Payment Breakdown by Category
Food & Beverage$11,775 (77.9%)
Other$1,534 (10.1%)
Consulting$1,340 (8.9%)
Education$463.96 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,775 | 603 | 77.9% |
| Consulting Fee | $1,340 | 2 | 8.9% |
| Honoraria | $1,135 | 2 | 7.5% |
| Education | $463.96 | 5 | 3.1% |
| Long term medical supply or device loan | $398.80 | 4 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,328 | 49 | $0 (2024) |
| PFIZER INC. | $1,265 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $913.58 | 44 | $0 (2024) |
| Deciphera Pharmaceuticals Inc. | $812.27 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $739.54 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $693.37 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $659.09 | 46 | $0 (2024) |
| GENZYME CORPORATION | $657.75 | 31 | $0 (2024) |
| Stemline Therapeutics Inc. | $548.26 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $534.68 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,712 | 135 | Novartis Pharmaceuticals Corporation ($629.47) |
| 2023 | $3,180 | 164 | E.R. Squibb & Sons, L.L.C. ($322.81) |
| 2022 | $4,267 | 168 | PFIZER INC. ($972.14) |
| 2021 | $3,955 | 149 | Deciphera Pharmaceuticals Inc. ($784.93) |
All Payment Transactions
616 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.85 | General |
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 12/13/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Genetic Disease | ||||||
| 12/11/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Consulting Fee | In-kind items and services | $440.00 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | REBLOZYL (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: HEMATOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: Hematology | ||||||
| 11/21/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Genentech USA, Inc. | Itovebi (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: BioOncology | ||||||
| 11/12/2024 | Genentech USA, Inc. | Itovebi (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: BioOncology | ||||||
| 11/08/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: Hematology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.08 | General |
| Category: Hematology/Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Oncology | ||||||
| 10/25/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 162 | 180 | $12,702 | $2,300 |
| 2022 | 8 | 191 | 346 | $21,216 | $3,317 |
| 2021 | 2 | 31 | 31 | $2,670 | $745.06 |
| 2020 | 1 | 15 | 15 | $1,713 | $659.72 |
Total Patients
399
Total Services
572
Medicare Billing
$7,022
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $3,000 | $923.26 | 30.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 39 | 43 | $3,225 | $445.05 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 46 | $1,380 | $378.00 | 27.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 41 | 46 | $3,450 | $350.06 | 10.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 21 | $1,575 | $188.80 | 12.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 12 | $72.00 | $14.92 | 20.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 11 | 13 | $6,292 | $1,090 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 19 | $3,325 | $970.35 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 40 | 42 | $3,150 | $436.80 | 13.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 44 | 47 | $3,525 | $359.59 | 10.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 12 | $2,160 | $224.99 | 10.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 44 | 47 | $1,410 | $136.74 | 9.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 14 | 14 | $1,050 | $83.48 | 8.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 152 | $304.00 | $14.80 | 4.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $2,100 | $688.06 | 32.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 19 | $570.00 | $57.00 | 10.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 15 | $1,713 | $659.72 | 38.5% |
About Kellie Clayton
Kellie Clayton is a Registered Nurse healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1669898433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kellie Clayton has received a total of $15,113 in payments from pharmaceutical and medical device companies, with $3,712 received in 2024. These payments were reported across 616 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,775).
As a Medicare-enrolled provider, Clayton has provided services to 399 Medicare beneficiaries, totaling 572 services with total Medicare billing of $7,022. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Knoxville, TN
- Active Since 03/17/2014
- Last Updated 05/07/2019
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1669898433
Products in Payments
- ORGOVYX (Drug) $946.89
- QINLOCK (Drug) $812.27
- KEYTRUDA (Biological) $797.23
- LIBTAYO (Biological) $738.12
- KISQALI (Drug) $667.92
- Orserdu (Drug) $548.26
- OPDIVO (Biological) $540.38
- IMBRUVICA (Drug) $516.04
- TAZVERIK (Drug) $485.45
- Enhertu (Drug) $348.50
- KRAZATI (Drug) $311.78
- REBLOZYL (Biological) $307.16
- MONJUVI (Drug) $302.38
- JAKAFI (Drug) $295.26
- PIQRAY (Drug) $270.53
- Lenvima (Drug) $268.10
- DARZALEX (Biological) $262.58
- VERZENIO (Drug) $257.30
- FOTIVDA (Drug) $245.92
- Trodelvy (Drug) $222.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Knoxville
Carol Hawkins, Np, NP
Registered Nurse — Payments: $20,626
Registered Nurse $20,626
Katherine Sullivan, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $16,882
Registered Nurse $16,882
Danielle Mote, Fnp, FNP
Registered Nurse — Payments: $11,874
Registered Nurse $11,874
Katherine Johnson, Aprn-Fnp-Bc, APRN-FNP-BC
Registered Nurse — Payments: $9,492
Registered Nurse $9,492
Melissa Spears, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Registered Nurse — Payments: $7,582
Registered Nurse $7,582
Stephanie Tipton, Aprn, APRN
Registered Nurse — Payments: $6,277
Registered Nurse $6,277